Research in the oncologic field will, in particular, provide a solution to the problem of toxicity of traditional chemotherapeutic agents, through the development of innovative tools and technologies that will contribute to new therapies or patient interventions. (eg. by the addition of a targeting function selective for cancer cells).
Since cancer shows a growing trend, due to the lifestyle as well as the progressively ageing population, drug delivery would represent an efficient therapeutic approach for about 12.5 million new yearly diagnosed cancer cases worldwide. To this, we can add the new market of personalized medicine and a growing demand for self-administration drugs, also resulting in reduction of time spent in health facilities.